Cancer patient with six months to live finishes third Great Manchester Run
She said: "Every finish line is borrowed time. It keeps me alive, physically and mentally," she said."Even if you're told the worst, never say never."
Ms Summers, from Fallowfield, has been taking part in the Great Manchester Run since 2005.But shortly after completing the race in 2021 she began suffering back pain which turned out to be a spinal tumour – a secondary cancer from a primary tumour in her lung. Doctors told Ms Summers that she might never walk again and gave her a prognosis of just six to 18 months. However, after beginning intensive chemotherapy, she began walking short distances with the help of Nordic hiking poles. "It was freezing, it was painful, but it gave me something to work towards," she said. "Walking every day gave me a sense of purpose again and helped relieve the pain."
Believing she was too ill to take part in the 2022 run, Ms Summers' daughter Josie rallied friends and family to take part in her mum's honour.Inspired by their support, Ms Summers made the decision to join them herself at the last minute – and has taken part every year since.Now more than 30-strong, their running group raises funds for cancer charity Maggie's, which supported Ms Summers and her family as they navigated her diagnosis. Ms Summers has undergone 36 rounds of chemotherapy and still attends scans every three months. The tumours are stable, allowing her to remain off chemotherapy for the past 12 months.She said she walked every day and trained for each 10K event with the same determination that got her through treatment, using her sticks for support."I can't run anymore, the pain's too much, but I can still walk. I take painkillers, I lean on my poles, and I get it done," she said.
Listen to the best of BBC Radio Manchester on Sounds and follow BBC Manchester on Facebook, X, and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
5 hours ago
- Daily Mail
Are YOUR dizzy spells being caused by hidden nervous system problems that GPs often fail to spot... and could the cure be a 30p pill?
For more than 20 years, mother-of-two Kerry Clayton endured dizzy spells, fainting and constant light-headedness – only to have her concerns repeatedly dismissed by doctors. Her symptoms first appeared in her teens when she fainted during an exam. At the time, it was put down to stress. But the episodes kept happening – at work, in busy crowds – until they became, as she puts it, 'part of everyday life'.
Daily Mail
5 hours ago
- Daily Mail
Fat jabs like Ozempic and Mounjaro threaten to push up pension age as life expectancy rises
The spread of 'fat jabs' such as Ozempic could lead to a rise in the state pension age because previously obese workers will live longer than expected, Government advisers have warned. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted. Users of the drugs, which also include Mounjaro and Wegovy, typically lose about 15 per cent of their body weight, leading to knock-on health benefits such as lower cholesterol levels and reduced blood pressure. Health Secretary Wes Streeting aims to widen the availability of the drugs on the NHS to lessen the burden on the Health Service and boost employment, arguing that 'our widening waistbands' are 'holding back our economy'. Illness as a result of obesity causes people to take an extra four sick days a year on average. But a Government source told The Mail on Sunday: 'Obviously everyone can see the health benefits. But some people in the Treasury are worried about the impact on the pension crisis. Obesity is a big killer. 'And if people are starting to live a lot longer because they're not overweight that's quickly going to become an issue. Especially if we're going to see it regularly being prescribed on the NHS, as Wes is advocating.' The NHS currently offers the medicines for the management of obesity in certain patients. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted (file image) The state pension age will officially rise next year from 66 to 67, and then again to 68 between 2044 and 2046 – although growing pressure on public funds means an upcoming pension review by Work and Pensions Secretary Liz Kendall could hike that age further. Chancellor Rachel Reeves is facing a £50billion 'fiscal hole' in the public finances she will need to close in Autumn's Budget: measures considered include tighter inheritance tax rules and an increase in 'sin taxes' on tobacco and gambling. The triple lock protection for the state pension is also becoming a growing burden, with spiking inflation predicted to push the full amount to £12,451 next year – a £478 rise from its current level of £11,973. According to the forecasts, the state pension will cost the Exchequer £151.42 billion that year – £430 million higher than the £150.99 billion bill anticipated as a result of previous Bank Of England inflation forecasts. Mr Streeting hopes the weight-loss jabs will ease the burden on the NHS' budget, which will rise by 3.3 per cent next year to £192 billion.
Daily Mail
5 hours ago
- Daily Mail
Surge in cannabis-induced psychotic episodes across the UK as potency of strains has increased
Cannabis-induced psychosis is becoming increasingly common across the UK, a leading psychiatrist has warned. The widely used class B drug – also known as marijuana or weed – can cause dependency, and, in the year to March 2024, 2.3million people in the UK reported using it. But while regular use has more than halved in the past two decades, the number of cannabis-induced psychosis episodes has spiked as varieties on sale have become stronger. Those experiencing a psychotic episode commonly have symptoms such as hallucinations, dissociation or unusual changes in behaviour. And while these resolve in most cases, side-effects can last for years. Studies show cannabis can even trigger schizophrenia – a chronic mental health condition characterised by psychotic episodes where individuals lose touch with reality, experiencing delusions and hallucinations. Dr Niall Campbell, a consultant psychiatrist at the Priory rehabilitation centre, warns of a deepening public health issue, stemming from easy online access to highly potent forms of the drug known as 'skunk'. Made from unpollinated cannabis plants which naturally contain higher levels of THC – the main psychoactive ingredient – skunk greatly increases the risk of paranoia and hallucinations. 'There has been a visible rise in the number of people needing intensive support for psychosis as a result of cannabis use,' said Dr Campbell. 'I don't think this is surprising given how easy skunk is to buy. What begins with smoking a few 'joints' and feeling a bit paranoid can easily escalate. Over time people can reach a psychotic state which won't go away, even if they stop smoking – they can become very depressed or suicidal.' It comes after the London Drugs Commission released a report earlier this year calling for more services to tackle cannabis addiction.
